Ding Y - Search Results

1

Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.

Huang D, Ding Y, Li Y, Luo WM, Zhang ZF, Snider J, Vandenbeldt K, Qian CN, Teh BT. Huang D, et al. Among authors: ding y. Cancer Res. 2010 Feb 1;70(3):1053-62. doi: 10.1158/0008-5472.CAN-09-3722. Epub 2010 Jan 26. Cancer Res. 2010. PMID: 20103629

2

Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.

Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, Teh BT. Huang D, et al. Among authors: ding y. Cancer Res. 2008 Jan 1;68(1):81-8. doi: 10.1158/0008-5472.CAN-07-5311. Cancer Res. 2008. PMID: 18172299

3

Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.

Huang D, Ding Y, Zhou M, Rini BI, Petillo D, Qian CN, Kahnoski R, Futreal PA, Furge KA, Teh BT. Huang D, et al. Among authors: ding y. Cancer Res. 2010 Feb 1;70(3):1063-71. doi: 10.1158/0008-5472.CAN-09-3965. Epub 2010 Jan 26. Cancer Res. 2010. PMID: 20103651 Free PMC article.

4

VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma.

Li Y, Zhang ZF, Chen J, Huang D, Ding Y, Tan MH, Qian CN, Resau JH, Kim H, Teh BT. Li Y, et al. Among authors: ding y. Am J Transl Res. 2010 May 20;2(3):296-308. Am J Transl Res. 2010. PMID: 20589168 Free PMC article.

5

Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.

Ding Y, Huang D, Zhang Z, Smith J, Petillo D, Looyenga BD, Feenstra K, Mackeigan JP, Furge KA, Teh BT. Ding Y, et al. Cancer Res. 2011 Aug 1;71(15):5225-34. doi: 10.1158/0008-5472.CAN-11-0076. Epub 2011 Jun 3. Cancer Res. 2011. PMID: 21642374

6

Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.

Ding Y, Boguslawski EA, Berghuis BD, Young JJ, Zhang Z, Hardy K, Furge K, Kort E, Frankel AE, Hay RV, Resau JH, Duesbery NS. Ding Y, et al. Mol Cancer Ther. 2008 Mar;7(3):648-58. doi: 10.1158/1535-7163.MCT-07-2229. Epub 2008 Mar 4. Mol Cancer Ther. 2008. PMID: 18319331

7

RNA sequencing reveals upregulation of RUNX1-RUNX1T1 gene signatures in clear cell renal cell carcinoma.

Xiong Z, Yu H, Ding Y, Feng C, Wei H, Tao S, Huang D, Zheng SL, Sun J, Xu J, Fang Z. Xiong Z, et al. Among authors: ding y. Biomed Res Int. 2014;2014:450621. doi: 10.1155/2014/450621. Epub 2014 Mar 25. Biomed Res Int. 2014. PMID: 24783204 Free PMC article.

8

The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancer.

Fu J, Ding Y, Huang D, Li H, Chen X. Fu J, et al. Among authors: ding y. Cancer Lett. 2007 Apr 8;248(1):153-63. doi: 10.1016/j.canlet.2006.06.012. Epub 2006 Oct 5. Cancer Lett. 2007. PMID: 17027148

9

Anti-tumor activity of a 3-oxo derivative of oleanolic acid.

Huang D, Ding Y, Li Y, Zhang W, Fang W, Chen X. Huang D, et al. Among authors: ding y. Cancer Lett. 2006 Feb 28;233(2):289-96. doi: 10.1016/j.canlet.2005.03.019. Epub 2005 Sep 9. Cancer Lett. 2006. PMID: 16154686

10

Development of an enzyme-linked immunosorbent assay (ELISA) for the specific detection of MEKK1 expression in cells.

Ding Y, Huang D, Chen XG. Ding Y, et al. J Pharmacol Toxicol Methods. 2005 Mar-Apr;51(2):159-67. doi: 10.1016/j.vascn.2004.08.004. J Pharmacol Toxicol Methods. 2005. PMID: 15767210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,212 results

Search Page

Filters